Various 4-bromomethylcoumarins (1a-k) were reacted with methyl salicylate to yield 2-(2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid methyl esters (2a-k). Formations of (3a-k) were achieved by using DBU under microwave irradiation. Structures of all the compounds were established on the basis of their spectral data. All the compounds were tested in vitro for their antimicrobial activity and cell cytotoxicity. All the tested compounds (2b-k) and (3a-k) were shown to be better activity against Staphylococcus aureus than the standard Ciprofloxacin. The compound (3k) (R = 6-OMe) was found to be more potent cytotoxic than the standard 5-fluorouracil.
Introduction
Benzofuran and its derivatives [1] have attracted considerable interest in recent years for their versatile properties in chemistry and pharmacology. 3-Benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin [2] was found to be the most potent antitubercular agent against Mycobacterium tuberculosis, even better than standard drug isoniazid. Benzofuran derivatives [3] were found to exhibit favorable antibacterial activity against Staphylococcus aureus and Bacillus subtilis which were better than the control drugs Cefotaxime and Ketoconazole. 2-Phenylbenzofurans [4] exhibited enhanced antiprotozoal activity against Trypanosoma brucei rhodesiense and Plasmodium falciparum. 2-Arylbenzofurans [5] were isolated from the roots of Glycyrrhiza uralensis. They showed significant in vitro protein tyrosine phosphate-1B inhibitory activity. Technetium-99m labeled pyridyl benzofuran derivatives [6] was tested as potential probes for imaging -amyloid plaques in Alzheimer's brains using single photon emission computed tomography.
Coumarin moieties are widely featured in a broad range of pharmacological and biologically active compounds [7, 8] . Phosphorohydrazine derivatives of coumarin displayed high in vivo antitumour activity against P388 leukemia [9] . Coumarin pyrazoline hybrids were found to possess the highest cytotoxicity against colorectal cell line HCT-116 with IC 50 value of 0.01 M [10] . Thiazolyl coumarin derivatives showed significant inhibition against Haemophilus influenzae with a MIC value of 15 M which is less than that of tetracycline [11] . Benzo [d] thiazolyl coumarins [12] demonstrated anti-HIV activity against HIV-1 cell with EC 50 < 7 g/mL.
Based on the survey of recent literature studies on coumarins and benzofurans and in our effort to discover novel antimicrobial [13] [14] [15] [16] and anticancer agents [17, 18] , the aim of our work is synthesis of 4-(3-hydroxy-benzofuran-2-yl)coumarins and the evaluation of them for their therapeutic importance.
Chemistry
The synthetic scheme for the target molecules was initiated by the Pechmann cyclisation of phenols with 4-bromoethylacetoacetate [19] leading to the required 4-bromomethylcoumarins [20] [21] [22] (1a-k). The compound 4-(6-methyl-2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid 2 Organic Chemistry International methyl ester [23] (2a) (R = 6-CH 3 ) was synthesized by reacting 4-bromomethyl-6-methylcoumarin and methyl salicylate in the presence of anhydrous K 2 CO 3 . Using this method, the compounds (2b-k) were synthesized. These intermediates (2a-k) did not yield the products (3a-k) in the presence of DBU in DMF under thermal conditions. However, when subjected to microwave irradiation afforded the compounds (3a-k) (Scheme 1). The completion of the reaction is monitored by TLC. A plausible mechanistic pathway proposed for the title compounds involves the generation of a carbanion at the active methylene group (C 4 -CH 2 ) which is stabilized by coumarin ring [24] . The intramolecular ring closure occurred when carbanion attacked the carbonyl carbon of methyl ester and eliminated methanol to form 4-(3-oxo-2,3-dihydro-benzofuran-2-yl)-coumarins that underwent in situ aromatization under the reaction conditions to yield 4-(3-hydroxy-benzofuran-2-yl)-coumarins ( Figure 1 ). The high melting solids separated in the reaction mixture were filtered off to obtain compounds (3a-k) as crystalline solids.
Results and Discussion
The structures of novel (2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid methyl esters and 4-(3-hydroxy-benzofuran-2-yl)-coumarins were established from IR, 1 H NMR, 13 C NMR, and LC-MS data as illustrated for a representative example. In the IR spectrum of 2-(7-methyl-2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid methyl ester (2b) (R = 7-CH 3 ), the lactone carbonyl stretching frequency was appeared at 1720 cm −1 , whereas the methyl ester carbonyl stretching frequency was observed at 1742 cm −1 . The 1 H NMR spectrum of the compound (2b) displayed a singlet at 2.40, 3.85, 5.52, and 6.85 due to CH 3 , OCH 3 , OCH 2, and C 3 -H protons, respectively. The aromatic protons resonated as a multiplet at 7.10-7.83. The IR spectrum of the compound 4-(3-hydroxybenzofuran-2-yl)-6-methylcoumarin (3a) (R = 6-CH 3 ) displayed a lactone carbonyl stretching frequency at 1729 cm −1 , whereas the -OH stretching frequency appeared at 3450 cm −1 . The 1 H NMR spectrum of the compound (3a) showed a singlet at 2.42 and 6.93 due to CH 3 and C 3 -H protons, respectively. The aromatic protons were resonated as a multiplet at 7.23-8.48. The -OH proton observed as a singlet at 11.42 that was confirmed by D 2 O exchange. The mass spectrum (LC-MS) of the compound (3g) displayed a [M+H] peak at 307. The 13 C NMR spectral data of compound (3h) are given in the experimental section.
Antimicrobial Activity
All the newly synthesized compounds (2b-k) and (3a-k) were screened for their antibacterial and antifungal activity at different concentrations of 100, 50, 25, 12.5, 6.25, 3.125, 1.6, 0.8, and 0.2 g/mL via broth microdilution method. The minimum inhibitory concentrations (MIC) were determined by serial dilution method [25] .
Antibacterial activity was carried out against three Grampositive bacteria, namely, Staphylococcus aureus, Enterococcus faecalis, and Streptococcus mutans, and three Gram-negative bacteria, namely, Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa. Ciprofloxacin was used as a standard. Antifungal activity was carried out against two fungi, namely, Candida albicans and Aspergillus fumigatus. Fluconazole was used as a standard.
The investigation of antimicrobial screening data (Table 1) showed that most of the tested compounds exhibited good bacterial and fungal inhibition. The compounds (2b) (R = 7-CH 3 ), (2c) (R = 6-Cl), (2e) (R = 6-F), and (2f) (R = 5,6-benzo) were found to be very active against S. mutans with MIC of 0.2 g/mL. The compounds (2c) (R = 6-Cl) and (2i) (R = 6-tert-butyl) were found to be highly active against E. coli with MIC of 0.2 g/mL. The compound (2i) (R = 6-tert-butyl) displayed high activity against A. fumigatus with MIC of 0.2 g/mL. The compounds (3a) (R = 6-CH 3 ) and (3b) (R = 7-CH 3 ) were found to be highly active against S. aureus, E. faecalis, and S. mutans with MIC of 0.2 g/mL. The compounds (3e) (R = 6-F) and (3f) (R = 5,6-benzo) were found to be highly active against S. aureus and C. albicans with MIC of 0.2 g/mL. The compounds (3g) (R = 6,8-dimethyl), (3h) (R = 6-isopropyl), (3i) (R = 6-tert-butyl), and (3j) (R = 6-benzyl) exhibited high activity against S. aureus, S. mutans, and C. albicans with MIC of 0.2 g/mL. The compound (3k) (R = OMe) showed high activity against S. aureus and C. albicans with MIC of 0.2 g/mL. It is to be noted that most of these compounds exhibited moderate activity against P. aeruginosa and inactive against K. pneumonia.
In general, uncyclized compounds (2b-k) are more potent than the cyclized compounds (3a-k) against S. mutans and E. coli. The cyclized compounds (3a-k) are more potent than the uncyclized compounds (2b-k) against E. faecalis and C. albicans. It is interesting to found that both cyclized and uncyclized compounds showed better activity against S. aureus than the standard Ciprofloxacin.
In Vitro Cell Cytotoxicity
All the newly synthesized compounds (2b-k) and (3a-k) were evaluated for their cytotoxicity against DAL cell using trypan blue dye exclusion assay. The detail procedure has been described in our earlier publications [26, 27] .
The investigation of in vitro cell cytotoxicity (Table 2) revealed that most of the tested compounds exhibited good activity. The compounds (2d) (R = 6-Br), (2h) (R = 6-isopropyl), (2i) (R = 6-tert-butyl), (2j) (R = 6-benzyl), (2k) (R = 6-OMe), (3a) (R = 6-CH 3 ), (3c) (R = 6-Cl), (3f) (R = 5,6-benzo), (3g) (R = 6,8-dimethyl), (3h) (R = 6-isopropyl), (3i) (R = 6-tert-butyl), and (3k) (R = 6-OMe) were found to be highly active (>70%) against DAL cell at the concentration of 100 g/mL. The compound (2f) (R = 5,6-benzo) was found to be poor active (25%) against DAL cell at the concentration of 100 g/mL. The rest of the compounds were found to be moderately active (>40%). In general, the cyclized compounds (3a-k) were found to be more potent than the uncyclized compounds (2b-k). Dry acetone, R = a; 6-CH 3 , b; 7-, c; 6-Cl, d; 6-Br, e; 6-F, f; 5,6-benzo, g; 6,8-dimethyl, h; 6-isopropyl, k; 6-OCH 3 .
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Scheme 1: Synthesis of compounds (2a-k) and (3a-k).
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Experimental Section
The melting points were measured with an electric melting point apparatus and are uncorrected. The IR spectra were obtained using a Shimadzu-8400S FT-IR spectrophotometer. 1 H NMR and 13 C NMR spectra in DMSO-6 solution were recorded at 25 ∘ C on a Bruker 300 and 400 MHz spectrometer, respectively. The 1 H chemical shifts were reported in ppm and referenced to TMS. The mass spectra were recorded on an Agilent-Single Quartz LC-MS. The purity of the compounds was checked by TLC. Microwave reactions were carried out on Milestone Laboratory's microwave reactor. The elemental analyses were carried out using Elemental Vario Micro Cube CHNS Rapid Analyzer. All the compounds gave satisfactory elemental analysis.
General Procedure for the Synthesis of Compounds (2a-k).
Methyl salicylate (0.304 g, 2.0 mmol) and anhydrous K 2 CO 3 (1.38 g, 10 mmol) were stirred in 25 mL of dry acetone for 30 min. 4-Bromomethylcoumarin (1a-k) (2.0 mmol) was added and stirring was continued for 24 h. The reaction mixture was concentrated to one-fourth volume and poured onto crushed ice. The solid separated was filtered and washed with 10 mL of 5% HCl. Then, it was washed with 50 mL of cold water. The crude product was dried and recrystallised from ethanol. 
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2-(6-Methoxy-2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid methyl ester (2k
General Procedure for the Synthesis of Compounds (3a-k).
A mixture of 2-(2-oxo-2H-chromen-4-ylmethoxy)-benzoic acid methyl ester (2a-k) (2.0 mmol), DBU (0.3 g, 2.0 mmol) and DMF (25 mL) were added to a microwave tube equipped with a magnetic stir bar. The microwave tube was fitted with a reflux condenser and irradiated in a microwave reactor at a temperature of 140 ∘ C for 4 min at a maximum power of 370 W. Then, completion of the reaction mixture was poured onto ice cold water and neutralized with dil HCl solution. The solid separated was filtered and washed with 100 mL of cold water. The crude product was dried and recrystallised from ethanol. 
4-(3-Hydroxy-benzofuran-2-yl)-6-methyl-chromen-2-one (3a
4-(3-Hydroxy-benzofuran-2-yl)-7-methyl-chromen-2-one (3b
4-(3-Hydroxy-benzofuran-2-yl)-6-flouro-chromen-2-one (3e
Conclusion
All the tested compounds (2b-k) and (3a-k) were shown to exhibit better activity against Staphylococcus aureus than the standard Ciprofloxacin. The compound (3k) (R = 6-OMe) was found to be more potent cytotoxic than the standard 5-fluorouracil.
